NFA
ACHN

Nationwide Fund Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Nationwide Fund Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-90,991
Closed -$409K – 2723
2017
Q3 		$409K Sell
90,991
-2,452
-3% -$10.9K ﹤0.01% 2282
2017
Q2 		$429K Buy
93,443
+12,303
+15% +$49.5K ﹤0.01% 2263
2017
Q1 		$342K Sell
81,140
-5,139
-6% -$21.3K ﹤0.01% 2360
2016
Q4 		$356K Buy
86,279
+9,112
+12% +$48.4K ﹤0.01% 2350
2016
Q3 		$625K Hold
77,167
– – ﹤0.01% 2064
2016
Q2 		$602K Buy
77,167
+1,606
+2% +$13.8K ﹤0.01% 2054
2016
Q1 		$599K Sell
75,561
-34,809
-32% -$255K ﹤0.01% 1994
2015
Q4 		$1.19M Sell
110,370
-6,587
-6% -$59.9K 0.01% 1640
2015
Q3 		$808K Buy
116,957
+6,380
+6% +$52K ﹤0.01% 1838
2015
Q2 		$980K Sell
110,577
-233,425
-68% -$2.21M ﹤0.01% 1871
2015
Q1 		$3.39M Buy
344,002
+270,441
+368% +$3.38M 0.01% 1175
2014
Q4 		$901K Sell
73,561
-990
-1% -$12.1K ﹤0.01% 1864
2014
Q3 		$744K Sell
74,551
-75
-0.1% -$696 ﹤0.01% 1977
2014
Q2 		$565K Buy
74,626
+559
+0.8% +$2.23K ﹤0.01% 2194
2014
Q1 		$244K Sell
74,067
-1,012
-1% -$3.54K ﹤0.01% 2400
2013
Q4 		$249K Sell
75,079
-156,276
-68% -$453K ﹤0.01% 2585
2013
Q3 		$699K Sell
231,355
-70,324
-23% -$482K ﹤0.01% 2043
2013
Q2 		$2.47M Buy
+301,679
New +$2.3M 0.01% 1176

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Nationwide Fund Advisors's ACHN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q4 2017, closing a stake of 90,991 shares — an estimated $409K sold.

Nationwide Fund Advisors first reported a position in ACHN in Q2 2013 and held it in 18 quarters. The position peaked at $3.39M in Q1 2015. 149 funds tracked by Wall St. Rank hold ACHN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Achillion Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 90,991 Achillion Pharmaceuticals shares in Q4 2017, an estimated $409K.
  • Nationwide Fund Advisors first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Achillion Pharmaceuticals position peaked at $3.39M in Q1 2015.
  • 149 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.